Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QScreen AIPMEDF -10.31% 3-Year EBITDA Growth Rate is 29.30% as of Jan. 2026, which is 42% above its 10-year median of 20.60. The stock has 1 warning sign investors should review. Among 690 Medical Devices & Instruments companies, QScreen AI ranks better than 76.38% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 29.30% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 23.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of QScreen AI was 29.30% per year. The lowest was -28.60% per year. And the median was 20.60% per year.
QScreen AI (OTCPK:PMEDF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
QScreen AI 3-Year EBITDA Growth Rate Related Terms
PMEDF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, QScreen AI's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QScreen AI 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QScreen AI's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where QScreen AI's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 29.30% mean?
QScreen AI (PMEDF) has a 3-Year EBITDA Growth Rate of 29.30% as of Jan. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for QScreen AI and its competitors. This is 42% above median its historical median of 20.60. According to the industry distribution chart, QScreen AI ranks #163 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 23.6%.
Is QScreen AI's 3-Year EBITDA Growth Rate too high?
QScreen AI's current 3-Year EBITDA Growth Rate of 29.30% is 42% above median its 10-year median of 20.60. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 8.20. QScreen AI's value of 29.30% is 257.3% above this industry median. Based on the distribution chart, QScreen AI ranks #163 out of 690 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does QScreen AI's 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, QScreen AI ranks #163 out of 690 companies for 3-Year EBITDA Growth Rate. This places QScreen AI in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 8.20. QScreen AI's value of 29.30% is 257.3% above this benchmark. While the company's 10-year median is 20.60 vs. the industry median of 8.20, QScreen AI has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 8.20, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QScreen AI's current 3-Year EBITDA Growth Rate of 29.30% is 257.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for QScreen AI and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QScreen AI's current 3-Year EBITDA Growth Rate is 29.30%, which is 42% above median its own 10-year median of 20.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QScreen AI stock overvalued right now?
QScreen AI (PMEDF) has a current 3-Year EBITDA Growth Rate of 29.30%. The current 3-Year EBITDA Growth Rate is 29.30%, which is 42% above median its 10-year median of 20.60 and 257.3% above the Medical Devices & Instruments industry median of 8.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For QScreen AI (PMEDF), the current 3-Year EBITDA Growth Rate is 29.30% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
QScreen AI Inc is focused on developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company's business is focused on artificial intelligence (AI) technologies targeting two specific areas: workplace health and safety and healthcare. It is building a proprietary artificial intelligence engine with quantum inspired computing and physiological sensing to clinical and occupational health assessments across correctional facilities, addiction medicine rehabilitation, and industrial workforce screening in multiple jurisdictions. It operates in single segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMEDF has been successfully added to your 
